Who owns Repare Therapeutics Ord?
- Ticker: RPTX
- CUSIP Number: 760273102
Tip: Access positions for across all investors
Analyze quarterly positions in Repare Therapeutics Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Repare Therapeutics Ord stock
Who bought or sold Repare Therapeutics Ord this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
BVF | 10M | $49M | 0% | Mar 2024 |
|
OrbiMed Advisors | 3.3M | $16M | 0% | Mar 2024 |
|
Blue Owl Capital Holdings | 3.1M | $15M | 0% | Mar 2024 |
|
ARK Investment Management | 2.7M | $13M | -4% | Mar 2024 |
|
Versant Venture Management | 2.6M | $13M | 0% | Mar 2024 |
|
MPM Asset Management | 2.2M | $11M | 0% | Mar 2024 |
|
Redmile Group | 2.0M | $9.5M | -6% | Mar 2024 |
|
MPM Oncology Impact Management | 1.6M | $7.7M | 0% | Mar 2024 |
|
Artal Group | 700k | $3.3M | 0% | Mar 2024 |
|
Aquilo Capital Management | 633k | $3.0M | 0% | Mar 2024 |
|
Ensign Peak Advisors | 344k | $1.6M | 0% | Mar 2024 |
|
Sumitomo Mitsui Trust Holdings | 308k | $1.5M | -5% | Mar 2024 |
|
Nikko Asset Management Americas | 308k | $1.4M | -5% | Mar 2024 |
|
Morgan Stanley | 288k | $1.4M | 471% | Mar 2024 |
|
Millennium Management | 169k | $795k | -7% | Mar 2024 |
|
HighVista Strategies | 165k | $778k | 0% | Mar 2024 |
|
Acadian Asset Management | 134k | $625k | 64% | Mar 2024 |
|
GSA Capital Partners | 126k | $594k | -13% | Mar 2024 |
|
D. E. Shaw & Co | 120k | $566k | 56% | Mar 2024 |
|
Bank Of Montreal | 105k | $510k | 0% | Mar 2024 |
|
Citadel Advisors | 73k | $345k | 1% | Mar 2024 |
|
Opaleye Management | 68k | $318k | 100% | Mar 2024 |
|
Two Sigma Investments | 67k | $314k | 162% | Mar 2024 |
|
BlackRock | 61k | $289k | -82% | Mar 2024 |
|
Harbor Capital Advisors | 61k | $286k | 26% | Mar 2024 |
|
Vanguard Group | 56k | $263k | -11% | Mar 2024 |
|
Exchange Traded Concepts | 55k | $257k | 302% | Mar 2024 |
|
Corton Capital | 46k | $218k | 66% | Mar 2024 |
|
Dimensional Fund Advisors | 41k | $192k | -7% | Mar 2024 |
|
Jump Financial | 40k | $289k | 100% | Dec 2023 |
|
Goldman Sachs Group | 36k | $171k | 25% | Mar 2024 |
|
Cubist Systematic Strategies | 35k | $167k | 33% | Mar 2024 |
|
American Century Companies | 32k | $153k | 81% | Mar 2024 |
|
Stifel Financial | 30k | $143k | 100% | Mar 2024 |
|
PDT Partners | 30k | $142k | 100% | Mar 2024 |
|
Susquehanna International | 27k | $128k | -91% | Mar 2024 |
|
Squarepoint Ops | 27k | $127k | -50% | Mar 2024 |
|
Geode Capital Management | 27k | $125k | 0% | Mar 2024 |
|
Blackstone Group | 26k | $122k | 0% | Mar 2024 |
|
Connor, Clark & Lunn Investment Management | 26k | $122k | 54% | Mar 2024 |
|
Bank of America Corporation | 23k | $108k | 6% | Mar 2024 |
|
ExodusPoint Capital Management | 21k | $99k | 100% | Mar 2024 |
|
Oracle Alpha | 20k | $92k | 59% | Mar 2024 |
|
Jane Street | 17k | $80k | -40% | Mar 2024 |
|
Occudo Quantitative Strategies | 15k | $73k | -50% | Mar 2024 |
|
Vontobel Holding | 15k | $71k | 0% | Mar 2024 |
|
Compagnie Lombard, Odier SCA | 14k | $66k | 0% | Mar 2024 |
|
Two Sigma Advisers | 12k | $55k | 100% | Mar 2024 |
|
Brevan Howard Capital Management | 11k | $52k | -30% | Mar 2024 |
|
CIBC World Markets | 11k | $49k | 100% | Mar 2024 |
|
SRS Capital Advisors | 10k | $73k | 100% | Dec 2023 |
|
Group One Trading | 7.6k | $36k | -42% | Mar 2024 |
|
Simplex Trading | 5.3k | $24k | -50% | Mar 2024 |
|
Tower Research Capital | 4.0k | $19k | -35% | Mar 2024 |
|
Lazard Asset Management | 3.0k | $0 | -70% | Dec 2023 |
|
Quantbot Technologies | 2.0k | $9.6k | 100% | Mar 2024 |
|
National Bank Of Canada /fi/ | 1.6k | $12k | -11% | Dec 2023 |
|
New York State Common Retirement Fund | 1.3k | $6.0k | 0% | Mar 2024 |
|
TD Waterhouse Canada | 1.3k | $5.4k | 0% | Mar 2024 |
|
Wells Fargo & Company | 1.1k | $5.4k | -3% | Mar 2024 |
|
Federation des caisses Desjardins du Quebec | 1.1k | $5.2k | 100% | Mar 2024 |
|
Qube Research & Technologies | 978.00 | $4.6k | 100% | Mar 2024 |
|
Barclays | 530.00 | $2.0k | 0% | Mar 2024 |
|
UBS Group | 518.00 | $2.4k | 7300% | Mar 2024 |
|
Royal Bank of Canada | 285.00 | $0 | -72% | Mar 2024 |
|
Citigroup | 34.00 | $160.000600 | 0% | Mar 2024 |
|
Jpmorgan Chase & Co | 4.00 | $19.000000 | 0% | Mar 2024 |
|
Who sold out of Repare Therapeutics Ord?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
T. Rowe Price Investment Management | Sep 2023 | 1.8M | $22M |
FMR | Sep 2023 | 1.1M | $13M |
Logos Global Management | Dec 2023 | 600k | $4.4M |
Sio Capital Management | Sep 2023 | 76k | $919k |
Algert Coldiron Investors | Sep 2023 | 31k | $371k |
Trexquant Investment | Sep 2023 | 30k | $356k |
Marshall Wace | Dec 2023 | 27k | $196k |
Belvedere Trading | Sep 2023 | 19k | $228k |
California State Teachers Retirement System | Sep 2023 | 17k | $202k |
Northern Trust | Sep 2023 | 15k | $178k |
Legal & General Group | Dec 2023 | 706.00 | $5.2k |